Tag: Vasculitis


FDA Advisors Split on New Drug for Vasculitis

May 7, 2021

Via: MedPageToday

Members of an FDA advisory panel were sharply divided as to whether avacopan, an oral small molecule inhibitor of the C5a receptor, was sufficiently safe and effective for treating antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. As to whether the efficacy data […]

Biomarker, Innovation

Researchers reveal promising biomarker for vascular disease relapse

February 28, 2019

Via: The Medical News

Antibodies are molecules produced by a human’s immune system to counteract bacteria and viruses. When a bacterial or viral pathogenic molecule (a so-called antigen) is detected, an antibody neutralizes it by binding to it. However, autoantibodies are sometimes produced against […]